|Bid||32.21 x 800|
|Ask||32.01 x 900|
|Day's Range||28.73 - 32.71|
|52 Week Range||12.29 - 32.71|
|Beta (5Y Monthly)||2.16|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul 28, 2021 - Aug 02, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||21.50|
With me today are Mark Ordan, our CEO; and Mark Richards, our CFO. Certain statements and information during this conference call may be deemed to be forward-looking statements within the meaning of the Federal Private Securities Litigation Reform Act of 1995.
What happened Shares of Mednax (NYSE: MD) were soaring 16.3% higher at 11:56 a.m. EDT on Friday. The big gain came after the company announced its first-quarter results before the market opened. So what Mednax reported net revenue in the first quarter of $446.
Mednax (MD) delivered earnings and revenue surprises of 60.00% and 2.36%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?